The meeting of the Advisory Committee on Vaccines (ACV).
The committee provided advice on one application to register a new vaccine, and one application to extend the indications of the vaccine.
The committee provided advice on one matter relating to pharmacovigilance.
- COVID-19 vaccine AstraZeneca [now, Vaxzevria] and Guillain Barre Syndrome
Members
Membership comprises professionals with expertise in specific scientific, medical or clinical fields, or consumer health issues.
Outcomes
-
Meeting statementsAdvisory Committee on Vaccines meeting statement